Kathryn King, PhD

Kathryn King, PhD, is a pharmaceutical industry executive with more than twenty-five years of clinical development achievements. Kathryn has held senior leadership roles at Pathos, Aptinyx, Levo, AbbVie, Takeda, Veeva Systems and Abbott. She is an experienced clinical trialist dedicated to designing and driving innovation in clinical research trials, with specialties in Risk-Based Monitoring, electronic Trial Master Files, and effective partnerships with Contract Research Organizations (CROs) and sites. She earned a BS in biochemistry from the University of Notre Dame, a MA in Health Care Ethics, and a PhD in Philosophy from Loyola University in Chicago.